Developing COVID-19 vaccines in less than a year came from repurposing multiple, decade-old vaccine research platforms, but too many lives were lost, and a new goal of developing vaccines in 100 days is needed to counter the next global pathogen, experts say.
Over 150 000 people who had TB in South Africa in 2018 were not diagnosed, according to findings from South Africa’s long-awaited National Tuberculosis Prevalence Survey. One reason for this is that an unexpectedly high number of people do not show the typical TB symptoms and are never x-rayed. Amy Green reports.
In allowing section 21 applications as part of a controlled compassionate access programme, SAHPRA has essentially shifted the responsibility for deciding whether the anti-parasitic ivermectin is safe and effective enough to be used in the treatment of COVID-19 to doctors. This places an enormous responsibility on doctors, writes Adele Baleta.
While likely millions of people in South Africa have latent tuberculosis (TB) infection, only between three and 10% of these people ever fall ill with TB. Cutting-edge research conducted in South Africa has now taken us a significant step closer to a test that can predict who will and who will not fall ill with TB. Such a test, if simple and affordable, could potentially revolutionise TB prevention efforts.
South Africa is set to produce its first vaccine in 25 years, but it won’t be a COVID-19 jab. Plans are however in place to “fill and finish” COVID-19 vaccines in South Africa. Laura Lopez Gonzalez has the details.
The U=U campaign is based on a simple message – an undetectable viral load in people living with HIV equals an untransmissible virus. The U=U campaign, argues Mandisa Dukashe, has the power to motivate people living with HIV to adhere to ARVs, achieve viral suppression, and subsequently lead long and healthy lives while preventing HIV transmission to sexual partners and their babies.
Before any COVID-19 vaccines can be made available in South Africa, they must be authorised by South Africa’s medicines regulator—the South African Health Products Regulatory Authority (SAHPRA). Catherine Tomlinson explores how SAHPRA is preparing to review and authorise the use of COVID-19 vaccines in the country and the different authorisation approaches they may use.
The recent budget policy statement shows South Africa finds itself in a very tight fiscal space where it has to navigate a global pandemic along with other health challenges such as rising rates of non-communicable diseases. Russell Rensburg argues that the Health Promotion Levy should be increased to 20% – which will raise much-needed revenue that will contribute to preventing disease and reducing healthcare costs.
Pharmacists do much more than stand behind a counter dispensing medicine. These professionals have a key role to play in the health care system and the overall well-being of people. Tiyese Jeranji spoke to a community pharmacist and pharmacists in the public health sector to understand their role and the challenges they face.
After more than 16 years at Red Cross War Memorial Children’s Hospital in Cape Town, Shihaam Cader and her team have helped to treat and rehabilitate thousands of malnourished children. Kathryn Cleary chatted to Cader for the first part of a six-part special series on child hunger in South Africa.
In 2019 around 360 000 people in South Africa fell ill with tuberculosis (TB) and about 58 000 people died due to the disease, according to a World Health Organization Report released last week. The COVID-19 pandemic has exacerbated these already alarming numbers, with some TB patients stopping treatment during lockdown. Siyabonga Kamnqa looks at the plans the Western Cape Health Department has in place to get its TB programme back on track and finds old challenges still remain.